Becton, Dickinson and Company Announces Results For 2017 Third Fiscal Quarter

FRANKLIN LAKES, N.J., Aug. 3, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $3.035 billion for the third fiscal quarter ended June 30, 2017. This represents a decrease of 5.1 percent from the prior-year period and is primarily due to the divestiture of the Respiratory Solutions business that was comple

Back to news